PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences Ltd (formerly Amradeep Industries) announced audited financial results for the quarter and year ended March 31, 2025, along with its Board Meeting outcome on May 19, 2025. Revenue from operations rose sharply from Rs. 3.59 lakhs (FY24) to Rs. 18.80 lakhs (FY25). The company reported a marginal net profit of Rs. 0.57 lakhs versus a net loss of Rs. 14.61 lakhs in the previous year. However, other equity remains deeply negative at Rs. (122.71) lakhs, reflecting accumulated losses, and current liabilities surged from Rs. 1.55 lakhs to Rs. 308.35 lakhs. The statutory auditor (Bipin & Co.) issued an unmodified (clean) opinion on the results.
The turnaround to profit is positive but rests on a very small revenue base, so operational scale remains limited. Negative net worth exceeding Rs. 122 lakhs and the steep rise in current liabilities are red flags shareholders should watch closely, despite the clean audit opinion.